AR035761A1 - Bacterias de acido lactico como agentes para tratar y prevenir la alergia - Google Patents
Bacterias de acido lactico como agentes para tratar y prevenir la alergiaInfo
- Publication number
- AR035761A1 AR035761A1 ARP020100732A ARP020100732A AR035761A1 AR 035761 A1 AR035761 A1 AR 035761A1 AR P020100732 A ARP020100732 A AR P020100732A AR P020100732 A ARP020100732 A AR P020100732A AR 035761 A1 AR035761 A1 AR 035761A1
- Authority
- AR
- Argentina
- Prior art keywords
- lactic acid
- acid bacteria
- allergy
- bacterial strains
- treat
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title abstract 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 4
- 208000026935 allergic disease Diseases 0.000 title abstract 3
- 230000007815 allergy Effects 0.000 title abstract 3
- 241000894006 Bacteria Species 0.000 title abstract 2
- 235000014655 lactic acid Nutrition 0.000 title abstract 2
- 239000004310 lactic acid Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- 230000001580 bacterial effect Effects 0.000 abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 241000186000 Bifidobacterium Species 0.000 abstract 1
- 241000186660 Lactobacillus Species 0.000 abstract 1
- 240000001046 Lactobacillus acidophilus Species 0.000 abstract 1
- 244000199866 Lactobacillus casei Species 0.000 abstract 1
- 241000186606 Lactobacillus gasseri Species 0.000 abstract 1
- 241001468157 Lactobacillus johnsonii Species 0.000 abstract 1
- 241000186605 Lactobacillus paracasei Species 0.000 abstract 1
- 241000186604 Lactobacillus reuteri Species 0.000 abstract 1
- 241000194036 Lactococcus Species 0.000 abstract 1
- 229940039696 lactobacillus Drugs 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Animal Husbandry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Birds (AREA)
- Wood Science & Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Cepas bacterianas del grupo de las bacterias de ácido láctico que expresan polipéptidos de superficie que contienen una secuencia peptídica que se asemeja al menos una parte de la región Fc de moléculas IgB. Las cepas bacterianas se seleccionan de los grupos Lactobacillus, Bifidobacterium o Lactococcus, y se derivan más preferentemente de los grupos de L. acidophilus, L. johnsonii, L. gasseri, L. casei, L. paracasei o L. reuteri. Composiciones alimenticias y farmacéuticas que contienen la cepa bacteriana. Uso de las cepas bacterianas para la preparación de un portador capaz de ser ingerido para el tratamiento de la alergia y/o prevención del comienzo de reacciones alérgicas. Uso de la composición alimenticia o farmacéutica antes citada para la preparación de un portador capaz de ser ingerido para el tratamiento de la alergia y/o prevención del comienzo de reacciones alérgicas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01105138A EP1239032A1 (en) | 2001-03-02 | 2001-03-02 | Lactic acid bacteria as agents for treating and preventing allergy |
Publications (1)
Publication Number | Publication Date |
---|---|
AR035761A1 true AR035761A1 (es) | 2004-07-07 |
Family
ID=8176657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020100732A AR035761A1 (es) | 2001-03-02 | 2002-02-28 | Bacterias de acido lactico como agentes para tratar y prevenir la alergia |
Country Status (17)
Country | Link |
---|---|
US (1) | US7235395B2 (es) |
EP (2) | EP1239032A1 (es) |
JP (1) | JP2004528034A (es) |
KR (2) | KR20030082950A (es) |
CN (1) | CN1505678A (es) |
AR (1) | AR035761A1 (es) |
AU (1) | AU2002256639B2 (es) |
BR (1) | BR0207749A (es) |
CA (1) | CA2438833A1 (es) |
IL (1) | IL157468A0 (es) |
MX (1) | MXPA03007881A (es) |
NO (1) | NO20033796L (es) |
NZ (1) | NZ527861A (es) |
PL (1) | PL367208A1 (es) |
RU (1) | RU2312892C2 (es) |
WO (1) | WO2002086102A1 (es) |
ZA (1) | ZA200307680B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004112773A1 (fr) * | 2003-04-24 | 2004-12-29 | Shin-Jen Shiao | Compositions pharmaceutiques utilisees pour le traitement de maladie immune et amelioration |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US7955834B2 (en) | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
US8252314B2 (en) | 2004-09-24 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Hypoallergenic composition |
WO2006093022A1 (ja) * | 2005-03-03 | 2006-09-08 | Meiji Dairies Corporation | 免疫機能調整剤 |
US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
EP1885383B1 (en) | 2005-05-31 | 2016-09-21 | IAMS Europe B.V. | Feline probiotic bifidobacteria |
AR052472A1 (es) | 2005-05-31 | 2007-03-21 | Iams Company | Lactobacilos probioticos para felinos |
JP2007300849A (ja) * | 2006-05-11 | 2007-11-22 | Oji Paper Co Ltd | ペットフード |
WO2008093303A2 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts |
CN102028224B (zh) * | 2007-06-21 | 2012-12-26 | 东宇生物科技股份有限公司 | 抗过敏的乳酸菌 |
KR100913405B1 (ko) * | 2008-03-25 | 2009-08-21 | 광주과학기술원 | Th2-매개 면역 질환의 예방 또는 치료용 조성물 |
EP2281871B1 (en) | 2008-04-25 | 2013-02-13 | Kameda Seika Co., Ltd. | Novel lactic acid bacterium having anti-allergic activity, anti-allergic agent, food and pharmaceutical composition each comprising the lactic acid bacterium, and process for production of the anti-allergic agent |
US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
US20100055082A1 (en) * | 2008-09-04 | 2010-03-04 | Jacques Alain Bauer | Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof |
CA2733249A1 (en) * | 2008-09-04 | 2010-03-11 | Om Pharma | Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof |
PT2429539T (pt) * | 2009-05-11 | 2017-01-12 | Nestec Sa | Lactobacilos johnsonii la1 ncc533 não replicativo (cncm i-1225) e distúrbios imunitários |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
CN102695427B (zh) | 2009-08-18 | 2016-04-13 | 雀巢产品技术援助有限公司 | 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物 |
US8889892B2 (en) | 2010-07-09 | 2014-11-18 | Sumitomo Chemical Company, Limited | Process for producing olefin oxide |
MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
TWI737955B (zh) * | 2018-01-12 | 2021-09-01 | 南韓商Gi創新股份有限公司 | 包含益生菌及IgE結合多肽的組成物及其用途 |
WO2024081219A1 (en) | 2022-10-14 | 2024-04-18 | Csp Technologies, Inc. | Container and method for storing and stabilizing moisture sensitive products |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242821A (en) | 1989-07-10 | 1993-09-07 | Valio, Finnish Co-Operative Dairies' Association | Lactococcus promoter and signal sequences for expression in bacteria |
GB9006400D0 (en) | 1990-03-22 | 1990-05-23 | Ciba Geigy Ag | Bacterial vectors |
US6737521B1 (en) * | 1990-05-11 | 2004-05-18 | The Rockefeller University | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
AU652920B2 (en) | 1990-08-30 | 1994-09-15 | Valio Ltd. | Promoter probe vectors, able to replicate in E.coli, B.subtilis, lactococci and lactobacillus as well as uses thereof |
GB9125695D0 (en) | 1991-12-03 | 1992-01-29 | Mastavac Limited | Medical preparations |
GB9400650D0 (en) * | 1994-01-14 | 1994-03-09 | Smithkline Beecham Biolog | Expression of surface lazer proteins |
AU2149495A (en) | 1995-04-11 | 1996-10-30 | Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno | Method for the construction of vectors for lactic acid bacte ria like lactobacillus such that the bacteria can efficientl y express, secrete and display proteins at the surface |
GB9518323D0 (en) * | 1995-09-07 | 1995-11-08 | Steidler Lothar | Materials and methods relating to the attachment and display of substances on cell surfaces |
DE69718150T3 (de) * | 1996-03-01 | 2009-03-05 | Novartis Ag | Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien |
JPH09234078A (ja) | 1996-03-04 | 1997-09-09 | Meiji Milk Prod Co Ltd | 乳酸菌用分泌ベクター及び該ベクターを用いたタンパク質の製造方法 |
ATE226637T1 (de) | 1996-09-06 | 2002-11-15 | Bioteknologisk Inst | Milchsäurebakterielles regulierbares expressionssystem |
US6642011B2 (en) * | 1998-04-15 | 2003-11-04 | Genencor International, Inc. | Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
US6835550B1 (en) * | 1998-04-15 | 2004-12-28 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
GB9908533D0 (en) * | 1999-04-14 | 1999-06-09 | Novartis Ag | Organic compounds |
KR20030034178A (ko) * | 2000-09-25 | 2003-05-01 | 소시에떼 데 프로듀이 네슬레 소시에떼아노님 | 알레르기 반응을 발달시키는 개인의 경향을 감소시킬 수있는 젖산 박테리아 |
ATE449861T1 (de) * | 2000-10-20 | 2009-12-15 | Bioneer As | Verfahren zur fermentativen herstellung von heterologen genprodukten in milchsäurebakterien |
EP1343894A4 (en) * | 2000-11-02 | 2005-05-04 | Univ Singapore | AOPB GENE, PROTEIN, HOMOLOGISTS, FRAGMENTS AND VARIANTS THEREOF, AND THE USE THEREOF FOR PRESENTATION ON THE CELL SURFACE |
-
2001
- 2001-03-02 EP EP01105138A patent/EP1239032A1/en not_active Withdrawn
-
2002
- 2002-02-28 AR ARP020100732A patent/AR035761A1/es unknown
- 2002-03-04 EP EP02726131A patent/EP1370640A1/en not_active Withdrawn
- 2002-03-04 WO PCT/EP2002/002326 patent/WO2002086102A1/en active IP Right Grant
- 2002-03-04 AU AU2002256639A patent/AU2002256639B2/en not_active Ceased
- 2002-03-04 MX MXPA03007881A patent/MXPA03007881A/es not_active Application Discontinuation
- 2002-03-04 CA CA002438833A patent/CA2438833A1/en not_active Abandoned
- 2002-03-04 CN CNA028090942A patent/CN1505678A/zh active Pending
- 2002-03-04 KR KR10-2003-7011522A patent/KR20030082950A/ko not_active Application Discontinuation
- 2002-03-04 PL PL02367208A patent/PL367208A1/xx not_active Application Discontinuation
- 2002-03-04 BR BR0207749-3A patent/BR0207749A/pt not_active Withdrawn
- 2002-03-04 RU RU2003129265/13A patent/RU2312892C2/ru not_active IP Right Cessation
- 2002-03-04 NZ NZ527861A patent/NZ527861A/en unknown
- 2002-03-04 KR KR1020087030377A patent/KR20080111172A/ko not_active Application Discontinuation
- 2002-03-04 IL IL15746802A patent/IL157468A0/xx unknown
- 2002-03-04 JP JP2002583617A patent/JP2004528034A/ja active Pending
-
2003
- 2003-08-26 NO NO20033796A patent/NO20033796L/no not_active Application Discontinuation
- 2003-08-29 US US10/652,502 patent/US7235395B2/en not_active Expired - Fee Related
- 2003-10-01 ZA ZA200307680A patent/ZA200307680B/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO20033796D0 (no) | 2003-08-26 |
AU2002256639B2 (en) | 2006-10-19 |
RU2312892C2 (ru) | 2007-12-20 |
WO2002086102A1 (en) | 2002-10-31 |
US20040265290A1 (en) | 2004-12-30 |
EP1239032A1 (en) | 2002-09-11 |
IL157468A0 (en) | 2004-03-28 |
MXPA03007881A (es) | 2003-12-04 |
KR20030082950A (ko) | 2003-10-23 |
ZA200307680B (en) | 2005-01-13 |
CN1505678A (zh) | 2004-06-16 |
JP2004528034A (ja) | 2004-09-16 |
NO20033796L (no) | 2003-10-31 |
CA2438833A1 (en) | 2002-10-31 |
RU2003129265A (ru) | 2005-04-10 |
BR0207749A (pt) | 2004-06-01 |
US7235395B2 (en) | 2007-06-26 |
PL367208A1 (en) | 2005-02-21 |
EP1370640A1 (en) | 2003-12-17 |
NZ527861A (en) | 2005-02-25 |
KR20080111172A (ko) | 2008-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR035761A1 (es) | Bacterias de acido lactico como agentes para tratar y prevenir la alergia | |
ES2969690T3 (es) | Lactobacillus casei o Lactobacillus paracasei para su uso en el tratamiento de infecciones por Clostridium difficile | |
ES2960781T3 (es) | Uso de comunidades microbianas para la salud humana y animal | |
ES2303357T3 (es) | Uso de una bacteria dotada de arginina deimanasa para inducir apoptosis y/o reducir una reaccion inflamatoria, y composiciones farmaceuticas o dieteticas que contienen dicha bacteria. | |
AR086677A2 (es) | Composicion de bacterias de acido lactico y su uso para hacer un suplemento alimentario de higiene o farmaceutica para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias | |
MX2011012069A (es) | Micro-organismos no-replicantes y su efecto inmuno estimulador. | |
BR9900972A (pt) | Uso de uma associação de lactobacilos para a preparação de uma composição para tratamento de vaginoses e vaginites, e composições farmacêuticas assim preparadas. | |
AR042313A1 (es) | Composicion bacteriana y su uso para inmunomudulacion y prevencion de la enfermedad inflamatoria intestinal | |
DK2270133T3 (en) | Method of obtaining a new strain of Bifidobacterium bidifum with effect against infection with Helicobacter pylori | |
RU2018120843A (ru) | Композиция кормовой добавки | |
RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
AR035683A1 (es) | Producto de consumo que contiene probioticos | |
SE0402406D0 (sv) | Probiotic lactobacillus strains for improved vaginal health | |
ATE290391T1 (de) | Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen | |
RU2010147343A (ru) | ИЗОЛИРОВАННЫЙ ШТАММ МИКРООРГАНИЗМА Lactobacillus plantarum Inducia DSM 21379 В КАЧЕСТВЕ ПРОБИОТИКА, УСИЛИВАЮЩЕГО ВРОЖДЕННЫЙ ИММУНИТЕТ ОРГАНИЗМА, ПРОДУКТ И КОМПОЗИЦИЯ, СОДЕРЖАЩИЕ УПОМОМЯНУТЫЙ МИКРООРГАНИЗМ, И ПРИМЕНЕНИЕ УПОМЯНУТОГО МИКРООРГАНИЗМА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, КОТОРОЕ УСИЛИВАЕТ КЛЕТОЧНЫЙ ИММУНИТЕТ | |
RU2014107770A (ru) | Композиция, содержащая n-ацетилцистеин и/или микроинкапсулированный защищенный от действия желудочного сока лизоцим в сочетании с пробиотическими бактериями, способная восстанавливать собственный барьерный эффект желудка, который утрачивается во время фармалогического лечения желудочной гиперацидности | |
BR112022004432A2 (pt) | Cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais | |
NZ516020A (en) | Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria | |
KR20180044313A (ko) | 프로피오니박테리움 아크네스로 인한 감염, 특히 여드름을 치료하는데 사용하기 위한 유산균 조성물 | |
AR109085A1 (es) | Uso de probióticos en el tratamiento y/o la prevención de la dermatitis atópica | |
Kitazawa et al. | Probiotics: immunobiotics and immunogenics | |
ATE367821T1 (de) | Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung | |
BR112022024128A2 (pt) | Composição de microbiota vaginal, e, método para tratar uma infecção | |
MX2022008666A (es) | Composicion probiotica para su uso como antioxidante. | |
DE60214029D1 (de) | Milchsäurebakterien und deren verwendungen zur behandlung von und vorbeugung gegen krebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |